By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT Second Quarter Fiscal Year 2022 Operational and Financial Results GBS, Inc. (NASDAQ:GBS) announced second quarter fiscal year ...

Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease ...

GUILLAIN BARRE SYNDROME DEFINITION. Guillain-Barre syndrome (GBS) is a rare but serious autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, leading to ...

Further analysis of efficacy data will be conducted in 2024. 15-HMedIdeS-09 is an open-label, single arm, trial evaluating the safety, tolerability and efficacy of imlifidase in GBS patients in ...

Since the GBS outbreak, 153 have been treated and discharged, 32 are in ICU and 18 on ventilator support, said the state health officials. Monday, Jul 07, 2025. New Delhi o C.

Guillain-Barré Syndrome: Doctor Warns Against Consumption Of Rice, Paneer & Other Foods Amid GBS Outbreak In Pune Dr. Priyanka Sehrawat, MD Medicine and DM Neurology at AIIMS Delhi, recently ...

Kochi: Kochi: The first GBS death was on Tuesday reported in Kerala after a 58-year-old died of Guillain-Barre Syndrome in Kochi.The patient was undergoing treatment in Kottayam Medical College.

On Tuesday, two patients with GBS symptoms were admitted to hospitals. At present, 19 patients are being treated for GBS at various hospitals in the State, revealed the health officials.

Another patient, a 16-year-old girl from Palghar, is in Nair Hospital with suspected GBS. So far, there are a total of 203 suspected cases and 176 confirmed cases in the state, with eight deaths.

Two more people succumbed to Guillain-Barré syndrome (GBS) in Maharashtra, raising the state's toll to 11 and the national count to 14. Nagpur and Kolhapur reported their first fatalities from ...